Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LUIS C DEVENECIA

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1750495792
CMS profile
79396
Location
OLNEY, IL

General Payments · PY2018–2024

$3,468.30

  • Reported across 205 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$601.16

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $601.16 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $104.17 5
Braeburn Inc. $62.06 3
Acerta Pharma LLC $61.41 4
Novo Nordisk AS $60.33 4
DEXCOM, INC. $52.56 2
Lilly USA, LLC $47.61 3
Amgen Inc. $45.43 3
NOVARTIS PHARMACEUTICALS CORPORATION $40.60 2
E.R. Squibb & Sons, L.L.C. $35.79 2
ABBVIE INC. $31.00 2
Mylan Specialty L.P. $27.57 2
Alvogen Inc $16.76 1
Axsome Therapeutics, Inc. $15.87 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $498.95 38
PY2019 $195.35 15
PY2020 $410.53 25
PY2021 $642.16 26
PY2022 $357.89 23
PY2023 $762.26 44
PY2024 $601.16 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $15.41 01/10/2024 Food and Beverage Undisputed 01/23/2026 1103615054 CMS
ABBVIE INC. $15.59 01/12/2024 Food and Beverage Undisputed 01/23/2026 1103615056 CMS
Alvogen Inc $16.76 08/12/2024 Food and Beverage Undisputed 01/23/2026 1137624076 CMS
Amgen Inc. $14.50 03/20/2024 Food and Beverage Undisputed 01/23/2026 1111562851 CMS
Amgen Inc. $16.66 10/02/2024 Food and Beverage Undisputed 01/23/2026 1111562853 CMS
Amgen Inc. $14.27 10/30/2024 Food and Beverage Undisputed 01/23/2026 1111562855 CMS
AstraZeneca Pharmaceuticals LP $15.11 03/07/2024 Food and Beverage Undisputed 01/23/2026 1104479982 CMS
AstraZeneca Pharmaceuticals LP $17.97 04/10/2024 Food and Beverage Undisputed 01/23/2026 1105450711 CMS
AstraZeneca Pharmaceuticals LP $13.56 07/24/2024 Food and Beverage Undisputed 01/23/2026 1104419471 CMS
AstraZeneca Pharmaceuticals LP $14.77 10/09/2024 Food and Beverage Undisputed 01/23/2026 1104221401 CMS
Axsome Therapeutics, Inc. $15.87 07/11/2024 Food and Beverage Undisputed 01/23/2026 1148299868 CMS
Braeburn Inc. $22.72 02/12/2024 Food and Beverage Undisputed 01/23/2026 1125604581 CMS
Braeburn Inc. $20.09 03/08/2024 Food and Beverage Undisputed 01/23/2026 1125604583 CMS
Braeburn Inc. $19.25 04/19/2024 Food and Beverage Undisputed 01/23/2026 1125604579 CMS
Dexcom, Inc. $24.26 02/16/2024 Food and Beverage Undisputed 01/23/2026 1153317670 CMS
Dexcom, Inc. $28.30 05/29/2024 Food and Beverage Undisputed 01/23/2026 1153317672 CMS
E.R. Squibb & Sons, L.L.C. $18.50 06/12/2024 Food and Beverage Undisputed 01/23/2026 1101304127 CMS
E.R. Squibb & Sons, L.L.C. $17.29 10/10/2024 Food and Beverage Undisputed 01/23/2026 1101304173 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.05 01/03/2024 Food and Beverage Undisputed 01/23/2026 1143214528 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.14 02/15/2024 Food and Beverage Undisputed 01/23/2026 1143214532 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.90 04/24/2024 Food and Beverage Undisputed 01/23/2026 1143214536 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.87 10/29/2024 Food and Beverage Undisputed 01/23/2026 1143214540 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.21 11/26/2024 Food and Beverage Undisputed 01/23/2026 1143214543 CMS
Lilly USA, LLC $14.66 02/26/2024 Food and Beverage Undisputed 01/23/2026 1135135212 CMS
Lilly USA, LLC $18.50 06/11/2024 Food and Beverage Undisputed 01/23/2026 1135160022 CMS
Lilly USA, LLC $14.45 07/24/2024 Food and Beverage Undisputed 01/23/2026 1135150356 CMS
Mylan Specialty L.P. $14.14 06/20/2024 Food and Beverage Undisputed 01/23/2026 1147286504 CMS
Mylan Specialty L.P. $13.43 10/22/2024 Food and Beverage Undisputed 01/23/2026 1147315254 CMS
Novartis Pharmaceuticals Corporation $17.29 03/27/2024 Food and Beverage Undisputed 01/23/2026 1086886267 CMS
Novartis Pharmaceuticals Corporation $23.31 11/20/2024 Food and Beverage Undisputed 01/23/2026 1086886281 CMS
Novo Nordisk Inc $16.69 04/16/2024 Food and Beverage Undisputed 01/23/2026 1097120992 CMS
Novo Nordisk Inc $15.20 06/27/2024 Food and Beverage Undisputed 01/23/2026 1096623054 CMS
Novo Nordisk Inc $15.07 07/09/2024 Food and Beverage Undisputed 01/23/2026 1097307075 CMS
Novo Nordisk Inc $13.37 11/05/2024 Food and Beverage Undisputed 01/23/2026 1097269893 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.